Trial Profile
Multi-centre, open-label, randomized and controlled phase I/II clinical trial of REX-003 for critical ischemia in lower limbs in insulinized type 2 diabetic patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs REX 003 (Primary)
- Indications Peripheral ischaemia
- Focus Adverse reactions; Therapeutic Use
- 09 Aug 2016 New trial record